Tag: Medical Equipment and Devices

Displaying 1 - 20 of 34 results.

Pages

Filtering by content type: Press Release

The Federal Trade Commission is sending refund checks totaling more than $350,000 to consumers who bought Willow Curve, a device that applies low-level light and, according to the agency, was deceptively advertised as an effective way to relieve pain.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that medical device company Stryker Corp.’s proposed $4 billion acquisition of competitor Wright Medical Group N.V. would violate federal antitrust law.
The Federal Trade Commission has approved an application by prosthetics manufacturer Otto Bock HealthCare North America, Inc. to divest to Proteor, Inc. certain assets it acquired when it consummated its acquisition of FIH Group Holdings, LLC, also known as Freedom Innovations, including all...
The Federal Trade Commission will require medical device companies Stryker Corp. and Wright Medical Group N.V. to divest all assets related to Stryker’s total ankle replacements and finger joint implant products to remedy concerns that Stryker’s proposed $4 billion acquisition of Wright will harm...
The Federal Trade Commission is currently accepting public comments on an application by prosthetics manufacturer Otto Bock HealthCare North America, Inc. (Ottobock) to divest to Proteor, Inc. certain assets it acquired when it consummated its acquisition of FIH Group Holdings, LLC (Freedom...
The Federal Trade Commission and the state of Wisconsin have sent warning letters to a company that placed newspaper advertisements and social media posts suggesting it could provide government stimulus money to customers to purchase their hearing aids.
The marketers of a low-level light therapy device (LLLT) called Willow Curve will have to stop making alleged deceptive claims that the device treats chronic, severe pain and associated inflammation, under a settlement with the Federal Trade Commission.
The Federal Trade Commission has closed its investigation into Johnson & Johnson’s proposed acquisition of the fibrin sealant surgical patch TachoSil from Takeda Pharmaceutical Company.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Boston Scientific’s proposed $4.2 billion acquisition of medical equipment and pharmaceutical supplier BTG plc would violate federal antitrust law.
Medical device company Boston Scientific Corp. has agreed to divest certain assets to Varian Medical Systems to settle Federal Trade Commission charges that Boston Scientific’s proposed $4.2 billion acquisition of medical equipment and pharmaceutical supplier BTG plc would violate federal antitrust...
The Federal Trade Commission issued a statement on its vote to close the investigation of the proposed merger of European eyewear makers Essilor and Luxottica Group.According to the statement, the evidence did not support a conclusion that Essilor’s proposed acquisition of Luxottica violates...
The Federal Trade Commission filed a complaint against the nation’s three largest dental supply companies alleging that they violated U.S. antitrust laws by conspiring to refuse to provide discounts to or otherwise serve buying groups representing dental practitioners.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that medical technology company Becton, Dickinson’s proposed $24 billion acquisition of competitor C. R. Bard would violate federal antitrust law by harming competition in two U.S.
Becton, Dickinson and Company and C. R. Bard, Inc. have agreed to divest two medical device product lines to settle Federal Trade Commission charges that Becton, Dickinson’s proposed $24 billion acquisition of Bard would negatively impact competition in those markets. Both companies supply a range...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Integra LifeSciences Holdings Corp.’s $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively impact competition in those markets. Both companies supply...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Abbott’s $8.3 billion acquisition of Alere.
Abbott Laboratories and Alere Inc. have agreed to a divestiture of two point-of-care medical device products line in order to settle Federal Trade Commission charges that Abbott’s proposed $8.3 billion acquisition of Alere will cause harm to competition.Abbott is a global healthcare company that...
Integra LifeSciences Holdings Corp. and Johnson & Johnson have agreed to a divestiture of five neurosurgical medical device product lines to settle Federal Trade Commission charges that Integra’s proposed $1 billion acquisition of Johnson & Johnson’s Codman Neuro division would negatively...
The Federal Trade Commission will host a workshop tomorrow in Washington, DC, to explore competition, innovation, and consumer protection issues raised by hearing health services and technology.The event is free and open to the public. It will be available via live webcast and live tweeted via...
The Federal Trade Commission has announced a final agenda for the Now Hear This: Competition, Innovation, and Consumer Protection Issues in Hearing Health Care workshop. The event will explore competition, innovation, and consumer protection issues raised by hearing health services and technology. 

Pages